<code id='2B777539A5'></code><style id='2B777539A5'></style>
    • <acronym id='2B777539A5'></acronym>
      <center id='2B777539A5'><center id='2B777539A5'><tfoot id='2B777539A5'></tfoot></center><abbr id='2B777539A5'><dir id='2B777539A5'><tfoot id='2B777539A5'></tfoot><noframes id='2B777539A5'>

    • <optgroup id='2B777539A5'><strike id='2B777539A5'><sup id='2B777539A5'></sup></strike><code id='2B777539A5'></code></optgroup>
        1. <b id='2B777539A5'><label id='2B777539A5'><select id='2B777539A5'><dt id='2B777539A5'><span id='2B777539A5'></span></dt></select></label></b><u id='2B777539A5'></u>
          <i id='2B777539A5'><strike id='2B777539A5'><tt id='2B777539A5'><pre id='2B777539A5'></pre></tt></strike></i>

          focus

          focus

          author:leisure time    Page View:4157
          close-up of psoriasis on a hand. -- biotech coverage from STAT
          A close-up of psoriasis on a hand. Adobe

          San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

          Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

          advertisement

          Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Chamber of Commerce, DOJ clash in court over drug prices
          Chamber of Commerce, DOJ clash in court over drug prices

          TheU.S.ChamberofCommercesuedtostopanewMedicaredrugpricenegotiationprogramfromgoingintoeffect.AdobeWA

          read more
          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more

          US ambassador visits Wall Street Journal reporter detained in Russia on charges of espionage

          WallStreetJournalreporterEvanGershkovichstandsinaglasscageinacourtroomattheMoscowCityCourtinMoscow,R